Raphas Co. Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: 0.031x

Raphas Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, Raphas Co. Ltd (214260) has a cash flow conversion efficiency ratio of 0.031x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩847.42 Million ≈ $574.29K USD) by net assets (₩27.54 Billion ≈ $18.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Raphas Co. Ltd (2017–2025)

Cash flow conversion efficiency of Raphas Co. Ltd from 2017 to 2025. This chart illustrates how Raphas Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Raphas Co. Ltd for real-time trading data and today's change.

Raphas Co. Ltd Cash Flow Conversion Ratio Explained

Raphas Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Raphas Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Raphas Co. Ltd ranked by their cash flow conversion efficiency. Also see Raphas Co. Ltd (214260) market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Lustrum Minerals Limited
AU:LRM
-0.285x
BIT Computer Co. Ltd
KQ:032850
0.031x
Burcelik Vana Sanayi ve Ticaret AS
IS:BURVA
-2.892x
Indiabulls Enterprises Limited
NSE:IEL
N/A
NDL Ventures Limited
NSE:NDLVENTURE
0.000x
PCF Group SA
WAR:PCF
0.081x
Vietnam National Seed Group JSC
VN:NSC
-0.100x
Yura Tech. Co. Ltd
KQ:048430
0.021x

Annual Cash Flow Conversion Efficiency for Raphas Co. Ltd (2017–2025)

The table below shows the annual cash flow conversion efficiency of Raphas Co. Ltd from 2017 to 2025. Review free cash flow generation of Raphas Co. Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩30.71 Billion
≈ $20.81 Million
₩1.43 Billion
≈ $970.87K
0.047x -71.96%
2024-12-31 ₩29.36 Billion
≈ $19.90 Million
₩4.88 Billion
≈ $3.31 Million
0.166x +397.25%
2023-12-31 ₩32.31 Billion
≈ $21.89 Million
₩-1.81 Billion
≈ $-1.23 Million
-0.056x +36.98%
2022-12-31 ₩40.93 Billion
≈ $27.74 Million
₩-3.63 Billion
≈ $-2.46 Million
-0.089x -639.31%
2021-12-31 ₩52.36 Billion
≈ $35.48 Million
₩862.01 Million
≈ $584.17K
0.016x -19.52%
2020-12-31 ₩44.18 Billion
≈ $29.94 Million
₩903.85 Million
≈ $612.53K
0.020x +135.31%
2019-12-31 ₩47.83 Billion
≈ $32.42 Million
₩-2.77 Billion
≈ $-1.88 Million
-0.058x -79.15%
2018-12-31 ₩20.13 Billion
≈ $13.64 Million
₩-651.09 Million
≈ $-441.23K
-0.032x +50.53%
2017-12-31 ₩23.74 Billion
≈ $16.09 Million
₩-1.55 Billion
≈ $-1.05 Million
-0.065x --

About Raphas Co. Ltd

KQ:214260 Korea Biotechnology
Market Cap
$40.34 Million
₩59.53 Billion KRW
Market Cap Rank
#22489 Global
#1449 in Korea
Share Price
₩7080.00
Change (1 day)
+0.57%
52-Week Range
₩6720.00 - ₩15190.00
All Time High
₩75400.00
About

Raphas Co., Ltd. manufactures and sells biodegradable microneedles in Korea. The company offers skin care, medical device, whitening care, and wrinkle care under the Acropass brand; and health food product under the FitKong brand. It also supplies double-layer microneedle manufacturing technology; and provides original development manufacturing, and contract development and manufacturing organiza… Read more